Daily Ards Research Analysis
Analyzed 12 papers and selected 3 impactful papers.
Summary
Across three observational cohorts, dynamic and early physiologic markers refine risk stratification in acute respiratory distress syndrome (ARDS) and trauma. Early blood glucose trajectories predict 30-day mortality in ARDS, admission fibrinogen thresholds forecast mortality and organ dysfunction after trauma, and higher BMI independently signals ARDS, sepsis, and multiorgan failure post-injury.
Research Themes
- Dynamic physiologic trajectories for ARDS prognostication
- Coagulation biomarkers to anticipate post-traumatic organ dysfunction
- Obesity as an independent risk marker after major trauma
Selected Articles
1. Predictive value of early blood glucose trajectory for poor prognosis in ARDS patients.
Using MIMIC-IV (n=8,103) with external validation (n=158), the authors identified four 48-hour blood glucose trajectories in ARDS. A dynamic trajectory (initially high, then sharply decreasing and slightly increasing) was linked to higher 30-day mortality, and a 16-predictor nomogram achieved AUCs of 0.72–0.75 with good calibration and clinical net benefit.
Impact: Introduces dynamic glycemic trajectories into ARDS prognostication with external validation and a practical nomogram, improving early risk stratification beyond static metrics.
Clinical Implications: Integrating early glucose trajectory into ICU risk models may help identify high-risk ARDS patients for tighter glycemic monitoring and protocolized interventions.
Key Findings
- Identified four 48-hour blood glucose trajectories in ARDS via GBTM; stable-low trajectory had the best survival.
- A dynamic trajectory starting high, then sharply decreasing and slightly increasing, was associated with significantly higher 30-day mortality (log-rank P<0.0001).
- A 16-predictor nomogram including glucose trajectory achieved AUC 0.72 (training) and 0.75 (external validation) with good calibration and net benefit.
Methodological Strengths
- Large training cohort from MIMIC-IV with external validation.
- Use of group-based trajectory modeling, Cox models, and decision curve analysis with calibration assessment.
Limitations
- Retrospective design with potential unmeasured confounding and selection bias.
- External validation set was small and single-center; glucose measurement frequency/timing may vary.
Future Directions: Prospective multicenter validation and interventional studies testing trajectory-informed glucose management strategies are warranted.
BACKGROUND: Patients with acute respiratory distress syndrome (ARDS) often develop stress-induced hyperglycemia, and glycemic variability is associated with adverse outcomes. Traditional static glycemic indicators cannot capture dynamic glucose changes, and current ARDS prognostic models lack integration of dynamic glycemic trajectories, leading to insufficient precision in early risk stratification. This study aimed to investigate the association between early glycemic trajectory and 30-day mortality in ARDS patients, while constructing and validating a prognostic prediction model integrating dynamic glycemic features. METHODS: A total of 8,103 ARDS patients from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database were enrolled as training set, and 158 patients from a single center served as external validation set. Group-based trajectory modeling (GBTM) was used to cluster the blood glucose trajectory within 48 h of admission. Independent prognostic factors were identified using Cox proportional hazards models, and a nomogram model was constructed. And the nomogram was validate using receiver operating characteristic curve, calibration curve and decision curve analysis. RESULTS: Four blood glucose trajectories were identified: G1 (20.01%), G2 (37.43%), G3 (34.64%) and G4 (7.91%). Among them, G2 group with stable and low blood glucose levels had the highest 30-day survival probability, while G4 group with an initial high blood glucose level that decreased sharply and then slightly increased had a significantly higher 30-day death (log-rank P < 0.0001). The nomogram integrating 16 predictors including glucose trajectory, age, respiratory rate, and anion gap achieved good discrimination (AUC = 0.72 in training set, 0.75 in validation set), favorable calibration, and high net clinical benefit. CONCLUSIONS: Early blood glucose trajectory is an independent predictor of 30-day mortality in patients with ARDS. The nomogram constructed based on dynamic blood glucose evolution has good predictive efficacy and clinical applicability, and can provide a quantitative tool for the early intervention of high-risk patients.
2. Elevating the standards of hypofibrinogenemia in trauma: Higher thresholds of admission fibrinogen predict mortality and organ dysfunction.
In 2,505 trauma patients, admission fibrinogen below 200 mg/dL was associated with higher 28-day and 24-hour mortality. Optimal fibrinogen cutoffs of <238 mg/dL predicted AKI and <235 mg/dL predicted ARDS, suggesting higher thresholds may better flag patients at risk of organ dysfunction.
Impact: Refines actionable fibrinogen thresholds that correlate with mortality, AKI, and ARDS, directly informing early trauma resuscitation priorities.
Clinical Implications: Consider earlier cryofibrinogen or fibrinogen concentrate replacement when admission levels are below 235–238 mg/dL, alongside protocolized trauma resuscitation to mitigate organ dysfunction risks.
Key Findings
- Admission fibrinogen <150 mg/dL (OR 11.86; 95% CI 5.80–24.26) and 150–199 mg/dL (OR 2.20; 95% CI 1.22–3.96) were associated with increased 28-day mortality.
- Fibrinogen <150 and 150–200 mg/dL also associated with higher 24-hour mortality.
- Optimal cutoffs predicted organ dysfunction: <238 mg/dL for AKI (OR 2.45; 95% CI 1.4–4.4) and <235 mg/dL for ARDS (OR 1.9; 95% CI 1.01–3.55).
Methodological Strengths
- Early standardized measurement within 30 minutes of arrival with predefined fibrinogen categories.
- Multivariable logistic regression adjusting for confounding, with clinically meaningful outcomes at 24 hours and 28 days.
Limitations
- Single-center retrospective design limits generalizability and causal inference.
- Potential residual confounding; fibrinogen assay variability and treatment interventions were not randomized.
Future Directions: Prospective, multicenter validation and randomized studies testing fibrinogen-guided resuscitation thresholds for mortality and ARDS prevention.
BACKGROUND: The precise thresholds at which admission fibrinogen predicts mortality and organ dysfunction in trauma patients are unknown. STUDY DESIGN AND METHODS: Retrospective study at a single trauma center. INCLUSION CRITERIA: 18-89 years, traumatic mechanism, transported from scene, and fibrinogen obtained within 30-min of arrival. Admission fibrinogen: <150, 150-199, 200-249, and ≥250 mg/dL. PRIMARY OUTCOME: 28-day mortality. Multivariable logistic regression analysis described the risk of 28-day mortality by fibrinogen levels. SECONDARY OUTCOMES: 24-h mortality, acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS). The optimal threshold of admission fibrinogen associated with AKI and ARDS was determined. Results reported as odds ratio (OR) with 95% confidence interval (CI). RESULTS: Two thousand five hundred and five patients included. Admission fibrinogen: 94 (3.8%) <150 mg/dL, 225 (9.0%) 150-199 mg/dL, 533 (21.3%) 200-249 mg/dL, and 1653 (66.0%) ≥250 mg/dL. Twenty-eight-day mortality occurred in 239/2505 (9.5%), and 114/2505 (4.6%) died within 24 h. Fibrinogen <150 mg/dL (OR: 11.86, 95% CI: 5.80-24.26; p < .001) and fibrinogen 150-199 mg/dL (OR: 2.20, 95% CI 1.22-3.96; p = .009) were associated with 28-day mortality. Admission fibrinogen <150 and 150-200 mg/dL were also associated with 24 h mortality. The optimal cutoff of fibrinogen and AKI was <238 mg/dL, which predicted AKI (OR: 2.45, 95% CI: 1.4-4.4). The optimal cutoff of fibrinogen and ARDS was <235 mg/dL, and predicted ARDS (OR: 1.9, 95% CI: 1.01-3.55). CONCLUSION: Admission hypofibrinogenemia <200 mg/dL is associated with 28-day and 24 h mortality in trauma patients. Admission fibrinogen is also a marker for post-traumatic AKI and ARDS.
3. BMI is independently associated with ARDS, sepsis and multiorgan failure after major trauma-results of a high-volume retrospective observational cohort study.
In a 1,514-patient trauma cohort, higher BMI independently associated with increased risks of ARDS, sepsis, and MOF, but not mortality, after adjustment for age, sex, ASA, and ISS. Findings support BMI as a clinically relevant risk marker for post-injury organ dysfunction.
Impact: Clarifies BMI’s independent contribution to key complications after major trauma, informing risk stratification and preventive strategies in ICU care.
Clinical Implications: Incorporate BMI into early post-trauma risk assessments to trigger enhanced monitoring, lung-protective strategies, and infection prevention bundles for patients with higher BMI.
Key Findings
- Among 1,514 adult trauma patients, higher BMI was independently associated with increased ARDS risk (adjusted OR 1.09 per unit increase).
- Higher BMI was also independently associated with sepsis and multiorgan failure, with no independent association with mortality.
- Multivariable models adjusted for BMI, age, sex, ASA status, and injury severity (ISS).
Methodological Strengths
- High-volume, contemporary single-center cohort with standardized inclusion (ISS ≥9 and/or ICU admission).
- Appropriate multivariable logistic regression adjusting for key confounders (age, sex, ASA, ISS).
Limitations
- Retrospective single-center design; potential residual confounding and limited generalizability.
- BMI is a crude proxy for adiposity; body composition and metabolic/inflammatory profiles were not captured.
Future Directions: Prospective multicenter studies incorporating body composition, metabolic markers, and targeted preventive bundles for high-BMI trauma patients.
BACKGROUND: Obesity is increasingly prevalent among trauma patients and has been proposed to influence post-injury inflammatory responses and organ dysfunction. However, evidence on the independent effect of body mass index (BMI) on in-hospital complications after major trauma remains conflicting. This study aimed to determine whether BMI is an independent predictor of specific adverse clinical outcomes in a large cohort of adult trauma patients. METHODS: This retrospective cohort study analyzed associations between BMI and adverse clinical outcomes (ARDS, pneumonia, sepsis, multiorgan failure (MOF) and mortality) among adult trauma patients at a German level-I trauma center between 2018 and 2024. Inclusion criteria were trauma leading to an Injury Severity Score (ISS) ≥ 9 and/or admission to the intensive care unit. Multivariable logistic regression adjusted for BMI, age, sex, ASA and ISS. RESULTS: A total of 1514 patients were included. Adjusted multivariate regression revealed BMI as being independently associated with an increased risk of ARDS (aOR 1.09 per kg/m CONCLUSIONS: A higher BMI was independently associated with ARDS, sepsis and MOF, but no independent association with mortality was detected in this cohort of adult trauma patients. This suggests that BMI may function as a clinically relevant risk marker.